Upgrade to SI Premium - Free Trial

Sensei Biotherapeutics (SNSE)

14.65 -1.95 (11.75%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (3/30/26 *Est.)

Latest Headlines

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 4, 2026 4:00 PM - BizWire Sensei Biotherapeutics (SNSE) Reiterated at Overweight by Cantor Fitzgerald June 4, 2026 7:00 AM - StreetInsider Form SCHEDULE 13G/A Sensei Biotherapeutics, Filed by: MILLENNIUM MANAGEMENT LLC June 3, 2026 4:53 PM - SEC Filing Form 10-K/A Sensei Biotherapeutics, For: Dec 31 June 2, 2026 9:01 AM - SEC Filing Sensei Biotherapeutics (SNSE) files for 24.87M share offering by selling stockholders June 2, 2026 9:00 AM - StreetInsider Form S-3/A Sensei Biotherapeutics, June 2, 2026 8:56 AM - SEC Filing Form 4 Sensei Biotherapeutics, For: Jun 01 Filed by: Cambrian BioPharma Inc June 1, 2026 5:22 PM - SEC Filing Form 4 Sensei Biotherapeutics, For: Jun 01 Filed by: Peyer James June 1, 2026 5:20 PM - SEC Filing Cantor Fitzgerald Starts Sensei Biotherapeutics (SNSE) at Overweight May 29, 2026 6:08 AM - StreetInsider Lucid Capital Markets Starts Sensei Biotherapeutics (SNSE) at Buy May 28, 2026 7:06 AM - StreetInsider Form DEFA14A Sensei Biotherapeutics, May 22, 2026 4:04 PM - SEC Filing Form 8-K Sensei Biotherapeutics, For: May 22 May 22, 2026 4:02 PM - SEC Filing Citi Starts Sensei Biotherapeutics (SNSE) at Buy May 22, 2026 5:01 AM - StreetInsider Form DEFA14A Sensei Biotherapeutics, May 21, 2026 5:14 PM - SEC Filing Form 8-K Sensei Biotherapeutics, For: May 21 May 21, 2026 5:12 PM - SEC Filing Form 4 Sensei Biotherapeutics, For: Apr 02 Filed by: MILLENNIUM GROUP MANAGEMENT LLC May 15, 2026 4:29 PM - SEC Filing Form 4 Sensei Biotherapeutics, For: Mar 31 Filed by: MILLENNIUM GROUP MANAGEMENT LLC May 15, 2026 4:28 PM - SEC Filing Form 4 Sensei Biotherapeutics, For: Mar 26 Filed by: MILLENNIUM GROUP MANAGEMENT LLC May 15, 2026 4:28 PM - SEC Filing Form 3 Sensei Biotherapeutics, For: Mar 26 Filed by: MILLENNIUM GROUP MANAGEMENT LLC May 15, 2026 4:27 PM - SEC Filing Form SCHEDULE 13G Sensei Biotherapeutics, Filed by: MILLENNIUM MANAGEMENT LLC May 15, 2026 4:07 PM - SEC Filing Form SCHEDULE 13G Sensei Biotherapeutics, Filed by: STEMPOINT CAPITAL LP May 15, 2026 10:01 AM - SEC Filing Form SCHEDULE 13G Sensei Biotherapeutics, Filed by: Caligan Partners LP May 15, 2026 8:32 AM - SEC Filing Form S-8 Sensei Biotherapeutics, May 15, 2026 8:13 AM - SEC Filing Form 10-Q Sensei Biotherapeutics, For: Mar 31 May 15, 2026 7:41 AM - SEC Filing Form 8-K Sensei Biotherapeutics, For: May 15 May 15, 2026 7:35 AM - SEC Filing Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update May 15, 2026 7:30 AM - BizWire "Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies May 14, 2026 11:12 AM - StreetInsider "Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies May 14, 2026 10:55 AM - Globe NewsWire Sensei Biotherapeutics doses first patient in breast cancer trial May 5, 2026 7:30 AM - StreetInsider Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer May 5, 2026 7:30 AM - BizWire Form 144 Sensei Biotherapeutics, Filed by: Cambrian BioPharma Inc April 29, 2026 3:27 PM - SEC Filing Sensei Biotherapeutics (SNSE) files for 24.87M share offering by selling stockholders April 28, 2026 7:29 AM - StreetInsider Form S-3 Sensei Biotherapeutics, April 28, 2026 7:24 AM - SEC Filing Form ARS Sensei Biotherapeutics, For: Dec 31 April 27, 2026 4:22 PM - SEC Filing Form DEFA14A Sensei Biotherapeutics, April 27, 2026 4:21 PM - SEC Filing Form DEF 14A Sensei Biotherapeutics, For: Jun 10 April 27, 2026 4:20 PM - SEC Filing Leerink Partners Starts Sensei Biotherapeutics (SNSE) at Outperform April 20, 2026 6:05 AM - StreetInsider Form 8-K Sensei Biotherapeutics, For: Apr 10 April 16, 2026 4:02 PM - SEC Filing Form PRE 14A Sensei Biotherapeutics, For: Jun 10 April 16, 2026 4:02 PM - SEC Filing Form 8-K/A Sensei Biotherapeutics, For: Feb 17 April 15, 2026 4:16 PM - SEC Filing Form 4 Sensei Biotherapeutics, For: Apr 10 Filed by: Craver Josiah April 14, 2026 5:19 PM - SEC Filing Form 4 Sensei Biotherapeutics, For: Apr 10 Filed by: Donenberg Phillip B. April 14, 2026 5:16 PM - SEC Filing Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference April 9, 2026 7:30 AM - BizWire Form 10-K Sensei Biotherapeutics, For: Dec 31 March 30, 2026 5:46 PM - SEC Filing Form 8-K Sensei Biotherapeutics, For: Mar 30 March 30, 2026 7:35 AM - SEC Filing Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update March 30, 2026 7:30 AM - BizWire The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology March 19, 2026 11:00 AM - StreetInsider Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 17, 2026 6:00 AM - BizWire Full Article List